Differential efficacy of dengue vaccine by immune status
Lancet
.
2015 May 2;385(9979):1726.
doi: 10.1016/S0140-6736(15)60889-3.
Authors
Isabel Rodriguez-Barraquer
1
,
Luis Mier-Y-Teran-Romero
2
,
Neil Ferguson
3
,
Donald S Burke
4
,
Derek A T Cummings
2
Affiliations
1
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: isabelr@jhu.edu.
2
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
3
Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK.
4
University of Pittsburgh Graduate School of Public Health.
PMID:
25943936
DOI:
10.1016/S0140-6736(15)60889-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Dengue / prevention & control*
Dengue Vaccines / administration & dosage*
Female
Humans
Male
Substances
Dengue Vaccines
Grants and funding
MR/K010174/1/MRC_/Medical Research Council/United Kingdom
U54 GM088491/GM/NIGMS NIH HHS/United States